STOCK TITAN

Vincerx Pharma (VINC) EPS by Year

VINC OTC

Vincerx Pharma Inc lost $15.85 per diluted share in fiscal year 2024. The table below carries 5 fiscal years, from 2020 to 2024, and the quarters Vincerx Pharma Inc has filed alongside them.

FY2024 annual
EPS (Diluted) -$15.85
Source SEC Filings Latest period Q1 FY2025, ended Mar 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VINC EPS (Diluted) by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY24FilingFY23FilingFY22FilingFY21FilingFY20Filing
EPS (Diluted)-$15.85-$37.72-$60.00n/m-$45.80-$63.20

VINC EPS (Diluted) by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'25FilingQ4'24FilingQ3'24FilingQ2'24FilingQ1'24FilingQ4'23FilingQ3'23FilingQ2'23FilingQ1'23FilingQ4'22FilingQ3'22FilingQ2'22Filing
EPS (Diluted)-$1.40N/A-$15.85-$1.00-$11.46-$4.60n/m-$37.72-$10.80n/m-$13.80n/m-$0.54n/m-$16.00n/m-$17.60n/m

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Vincerx Pharma Inc financials

Frequently Asked Questions

Vincerx Pharma Inc lost $15.85 per diluted share in fiscal year 2024.

Across the 5 fiscal years this page covers, Vincerx Pharma Inc (VINC) diluted earnings per share went from -$63.20 in fiscal year 2020 to -$15.85 in fiscal year 2024.

Vincerx Pharma Inc (VINC) reported -$1.40 in diluted earnings per share in Q1 2025.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Vincerx Pharma Inc (VINC) reported on that line in every period on record.